Hatteras Venture Partners

About Hatteras Venture Partners

Hatteras Venture Partners is dedicated to building transformational human medicine companies that benefit patients and healthcare professionals through innovative therapies and disruptive technologies.

Products & Services

Tune Therapeutics:A preclinical-stage start-up focused on developing a versatile epigenetic editing platform with multiple effectors for various applications.

Atacor Medical:Developing an extracardiac, extravascular approach to cardiac pacing and defibrillation.

Iris Healthcare:Delivers improved health outcomes, member experience, and cost savings through intuitive and customizable Advance Care Planning solutions.

Atsena:A clinical-stage AAV gene therapy company focused on genetic medicine to reverse or prevent blindness.

StrideBio:Developing engineered viral vectors for gene therapy using structure-inspired design to evade neutralizing antibodies.

G1 Therapeutics:A clinical-stage company developing small-molecule therapies for significant unmet needs in oncology.

Elligo Health Research:Provides on-demand clinical research infrastructure to enable physician practices to offer clinical trial participation.

Ribometrix:Developing small molecules targeting functional 3D RNA structures to treat human disease.

Contego Medical:Developing an integrated embolic protection platform to improve safety and efficacy of catheter-based interventions.

Standard Bariatrics:Developing a new standard in the surgical treatment of obesity.

Specialties

Human Medicine Transformative Therapies Disruptive Technologies Gene Therapy Epigenetic Editing Cardiac Pacing and Defibrillation Advance Care Planning Oncology Clinical Research Infrastructure RNA-Targeted Small Molecules Embolic Protection Bariatric Surgery

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Venture Fund Raising T: - FT: Venture Fund Raising	A: 200000000 MR: - FA: over $200 million FAN: 200000000	D: 2025-08-13 FD: 2025-08-13	-

Venture Fund Raising Latest

2025-08-13

$200.0M

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

John Crumpler

General Partner

LinkedIn (Pro only)

M

Myla Lai-Goldman, MD

Venture Partner

LinkedIn (Pro only)

C

Clay B. Thorp

General Partner

LinkedIn (Pro only)

M

Michael Dial, PhD

General Partner

R

Robert A. Ingram

General Partner at Hatteras

F

Fred Goldwater

Venture Partner

View 24 more team members with Pro

Unlock Full Team Directory

Recent News